Drug Shortage Report for COZAAR
Report ID | 109707 |
Drug Identification Number | 02182815 |
Brand name | COZAAR |
Common or Proper name | losartan potassium tablets |
Company Name | ORGANON CANADA INC. |
Market Status | MARKETED |
Active Ingredient(s) | LOSARTAN POTASSIUM |
Strength(s) | 25MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | C09CA |
ATC description | ANGIOTENSIN II ANTAGONISTS, PLAIN |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2020-05-04 |
Actual start date | |
Estimated end date | 2020-05-08 |
Actual end date | 2020-05-01 |
Shortage status | Avoided shortage |
Updated date | 2020-05-01 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 16766 ROUTE TRANSCANADIENNE KIRKLAND, QUEBEC CANADA H9H 4M7 |
Company contact information | 1-844-820-5468 dpoc.canada@organon.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2020-03-27 | English | Compare |
v2 | 2020-03-27 | French | Compare |
v3 | 2020-04-24 | English | Compare |
v4 | 2020-05-01 | English | Compare |
Showing 1 to 4 of 4